Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
ORGANO, The Current Fiscal Year Ordinary Profit Revised Upward by 9%, Raises Record High Profit Forecast
6368 ORGANO CORPORATION 【J-GAAP】
Earnings ReportORGANO CORPORATION <6368> [TSE Prime] announced its financial results after the market closed on February 5th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) expanded 19.9 billion yen, an increase 33.7% compared to the same period last year.
In addition, the full-year consolidated ordinary profit has been revised upward 8.8%, from the previous forecast of 28.5 billion yen to 31 billion yen (compared to 23.4 billion yen in the previous period), increasing the growth rate from 21.7% to 32.3%, further surpassing the previous forecast of record-high profits for four consecutive terms.
Based on the full-year plan announced by the company after the upward revision, our estimate of the consolidated ordinary profit for the October to March period (2H) is expected to increase 15.1%, from the previous forecast of 16.5 billion yen to 19 billion yen (compared to 14.8 billion yen in the same period of the previous year), increasing the growth rate from 11.2% to 28.0%.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit grew 25.5% from the same period last year, reaching 7.99 billion yen. The operating profit margin rose from 15.5% in the same period last year to 20.0%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 95,127 | 9,940 | 10,986 | 7,552 | 164.7 | 68.6 | Feb 1, 2023 | J-GAAP |
Apr - Dec, 2023 | 106,236 | 14,194 | 14,910 | 10,250 | 223.2 | 63.6 | Feb 2, 2024 | J-GAAP |
Apr - Dec, 2024 | 115,698 | 19,746 | 19,939 | 13,965 | 303.8 | 64.3 | Feb 5, 2025 | J-GAAP |
YoY | +8.9% | +39.1% | +33.7% | +36.2% | +36.1% |
Guidance Update
Second Half Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2024 Prev | 90,677 | 16,520 | 16,554 | 13,366 | 290.8 | 71 | Nov 1, 2024 | J-GAAP |
Oct - Mar, 2024 New | 93,177 | 19,520 | 19,054 | 14,866 | 323.4 | 71 | Feb 5, 2025 | J-GAAP |
Revision Rate | +2.8% | +18.2% | +15.1% | +11.2% | +11.2% |
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Prev | 165,000 | 28,000 | 28,500 | 21,500 | 467.7 | 142 | Nov 1, 2024 | J-GAAP |
Mar, 2025 New | 167,500 | 31,000 | 31,000 | 23,000 | 500.4 | 142 | Feb 5, 2025 | J-GAAP |
Revision Rate | +1.5% | +10.7% | +8.8% | +7.0% | +7.0% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 84,887 | 14,689 | 14,886 | 11,772 | 256.3 | 61 | May 13, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 93,177 | 19,520 | 19,054 | 14,866 | 323.4 | 71 | Feb 5, 2025 | J-GAAP |
YoY | +9.8% | +32.9% | +28.0% | +26.3% | +26.2% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 132,426 | 15,212 | 16,020 | 11,730 | 255.8 | 62 | May 12, 2023 | J-GAAP |
Mar, 2024 | 150,356 | 22,544 | 23,425 | 17,310 | 376.9 | 102 | May 13, 2024 | J-GAAP |
Mar, 2025 Guidance | 167,500 | 31,000 | 31,000 | 23,000 | 500.4 | 142 | Feb 5, 2025 | J-GAAP |
YoY | +11.4% | +37.5% | +32.3% | +32.9% | +32.8% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 40,767 | 6,339 | 6,371 | 4,712 | 102.6 | 15.5 | Feb 2, 2024 | J-GAAP |
Jan - Mar, 2024 | 44,120 | 8,350 | 8,515 | 7,060 | 153.7 | 18.9 | May 13, 2024 | J-GAAP |
Apr - Jun, 2024 | 31,619 | 4,001 | 4,368 | 2,676 | 58.3 | 12.7 | Jul 31, 2024 | J-GAAP |
Jul - Sep, 2024 | 42,704 | 7,479 | 7,578 | 5,458 | 118.8 | 17.5 | Nov 1, 2024 | J-GAAP |
Oct - Dec, 2024 | 41,375 | 8,266 | 7,993 | 5,831 | 126.9 | 20.0 | Feb 5, 2025 | J-GAAP |
YoY | +1.5% | +30.4% | +25.5% | +23.7% | +23.6% |
Related Articles
FUJI KYUKO, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 7%
Noevir, Oct-Dec (1Q) Ordinary Profit Decreases by 8%
NIHON KOHDEN, Oct-Dec (3Q) Ordinary Profit Increases by 16 times
TOBU RAILWAY, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 2%
AI Inc, Apr-Dec (Cumulative 3Q) Net Income Turns to Loss, Oct-Dec Net Income Turns to Loss
NISHIO HOLDINGS, Oct-Dec (1Q) Ordinary Profit Increases by 16%
SHOFU, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 22%, Oct-Dec Ordinary Profit Increases by 14%
SBI RHEOS HIFUMI, 11% Increase in Undisclosed Ordinary Profit, Record High for The First Time in Three Years
WAKAMOTO PHARMA, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Widens, Oct-Dec Ordinary Profit Turns to Loss
Naikai Zosen, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 63%, Exceeds Full-Year Plan